Redcare Pharmacy, NL0012044747

Redcare Pharmacy stock slips to EUR 67.65, down 0.59%

Published on 11/17/2026 at 08:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Barclays kept its Buy rating and raised its price target to EUR 86 on November 13. On Xetra, the stock closed at EUR 68.05 on Monday, November 16, 2026.

Key points for investors

  • Barclays maintained its Buy rating for Redcare Pharmacy on November 13 and raised its price target from EUR 85 to EUR 86.
  • The online pharmacy serves customers across European markets.
Redcare Pharmacy, NL0012044747, Illustration mit AI erstellt.

Redcare Pharmacy stock traded at 67.65 euros on Lang & Schwarz at 08:24 CET on Tuesday, November 17, 2026, 0.59 percent below the Xetra close of Monday, November 16, at 68.05 euros.

The Dutch company operates an online pharmacy serving European markets. Barclays maintained its Buy rating on November 13 and raised its price target from EUR 85 to EUR 86, according to Markets Insider.

The revised target keeps analyst attention on prescription growth, sales momentum and the companys path to stronger profitability. Barclays decision came after Redcare Pharmacy reported third-quarter results and kept its 2026 targets unchanged.

The AEX is the relevant broad equity-market reference for the Dutch-listed company.

More news and analyses on Redcare Pharmacy stock

Disclaimer...
en | NL0012044747 | REDCARE PHARMACY | boerse | 70525345 | bgmi